A structured, clinician-guided taper when you reach your goal
Key takeaways: Hashimotos and hypothyroidism do not automatically disqualify you Only medullary thyroid cancer and MEN-2 are true contraindications Weight loss may require thyroid medication adjustment Personalized endocrine care makes all the difference Whether youre located in Lafayette, San Francisco, the Bay Area, or anywhere in California via telemedicine , these decisions for my patients are always made through thoughtful, one-on-one discussions
Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide
Glucagon-like peptide-1 (GLP-1) receptor agonists are FDA-approved medications for type 2 diabetes and weight management, but currently no GLP-1 patches are approved for use in the United States
Kantar Retail IQs research proves that GLP-1 users are actively seeking this type of help
While microdosing programs are not intended for significant weight loss, program participants may experience reduced appetite and cravings, leading to gradual, sustained weight management